EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer

Tzu-Lei Kuo, Kuan-Chung Hsiao, Ko-Jiunn Liu, Li-Tzong Chen, Wen-Chun Hung

Cancer Immunology, Immunotherapy · 2026

DOI: 10.1007/s00262-026-04498-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Tzu-Lei Kuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Cancer Research, National Health Research Institutes, No. 367, Sheng-Li Road, Tainan, 704, Taiwan. Hauptthemen laut MEDLINE: Receptors, Interleukin-8B, Pancreatic Neoplasms, Neutrophils, Immunotherapy. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Interleukin-8BPancreatic NeoplasmsNeutrophilsImmunotherapyDNA-Binding ProteinsCarcinoma, Pancreatic DuctalTranscription FactorsAntibodies, MonoclonalAnimalsHumansMiceTumor MicroenvironmentCell ProliferationCell Line, TumorAntineoplastic Agents, Immunological

Stichwörter der Autor:innen

AT-rich interactive domain-containing protein 1AC-X-C chemokine receptor 2ImmunotherapyPancreatic ductal adenocarcinoma

Substanzen

Receptors, Interleukin-8BDNA-Binding ProteinsTranscription FactorsAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalCXCR2 protein, human

Autor:innen und Institutionen

  • National Institute of Cancer Research, National Health Research Institutes, No. 367, Sheng-Li Road, Tainan, 704, Taiwan.
  • Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • National Institute of Cancer Research, National Health Research Institutes, No. 367, Sheng-Li Road, Tainan, 704, Taiwan. hung1228@nhri.edu.tw.
  • Department of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan. hung1228@nhri.edu.tw.

Förderung

  • National Science and Technology Council

Zitieren

APA

Kuo, T. L., Hsiao, K. C., Liu, K. J., Chen, L. T., & Hung, W. C. (2026). Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04498-6

Vancouver

Kuo TL, Hsiao KC, Liu KJ, Chen LT, Hung WC. Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04498-6

BibTeX
@article{Kuo2026,
  author = {Kuo, Tzu-Lei and Hsiao, Kuan-Chung and Liu, Ko-Jiunn and Chen, Li-Tzong and Hung, Wen-Chun},
  title = {Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-026-04498-6}
}
Kostenlos starten →